1. Home
  2. TLSA vs RSSS Comparison

TLSA vs RSSS Comparison

Compare TLSA & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

BUY

Current Price

$1.60

Market Cap

182.7M

Sector

Health Care

ML Signal

BUY

Logo Research Solutions Inc

RSSS

Research Solutions Inc

HOLD

Current Price

$2.91

Market Cap

97.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLSA
RSSS
Founded
2013
2006
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
182.7M
97.3M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
TLSA
RSSS
Price
$1.60
$2.91
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$5.00
AVG Volume (30 Days)
420.3K
75.7K
Earning Date
05-06-2025
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.04
Revenue
N/A
$49,325,684.00
Revenue This Year
N/A
$4.92
Revenue Next Year
N/A
$7.09
P/E Ratio
N/A
$73.25
Revenue Growth
N/A
5.83
52 Week Low
$0.63
$2.32
52 Week High
$2.60
$4.24

Technical Indicators

Market Signals
Indicator
TLSA
RSSS
Relative Strength Index (RSI) 43.87 48.60
Support Level $1.45 $2.82
Resistance Level $1.62 $3.05
Average True Range (ATR) 0.16 0.13
MACD -0.00 0.01
Stochastic Oscillator 46.15 47.66

Price Performance

Historical Comparison
TLSA
RSSS

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides vertical software-as-a-service ("SaaS") and artificial intelligence ("AI") solutions, providing software and related services to help research-intensive organizations simplify the research process, save time, and money. The company operates in a single segment, which derives its revenue from subscription fees from its cloud-based SaaS Platforms and transactional service fees for the electronic delivery of single articles. The company generates the majority of its revenue from the Transactions. Geographically, the company generates the majority of its revenue from the United States, followed by Europe.

Share on Social Networks: